In contrast, downregulation of the IGF-IR induced by fenofibrate has only a modest contribution to the inhibition of Glioma cell motility despite the fact that IGF-I stimulates invasiveness of IGF-I-responsive LN-229 cells. Here, IGF1 is linked to central nervous system cancer.